Context: Nonalcoholic fatty liver disease (NAFLD) is a focus of attention because of its prevalence. CXC motif ligand 16 (CXCL16) has been studied in inflammatory and metabolic diseases.
N onalcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is prevalent in Western countries, and its incidence is increasing rapidly in Asia (1) . The hallmark of NAFLD is steatosis, with progression to steatohepatitis and fibrosis, accompanied by inflammation (2) . The liver is the main organ in the body responsible for energy supply via the metabolism of glucose, lipids, and amino acids (1) . Long-term aberrant lipid metabolism, which is associated with a risk of liver steatosis, plays a pivotal role in liver injury (3) . Steatosis, inflammation, and fibrosis interact and aggravate each other during NAFLD progression (4) . Nonalcoholic steatohepatitis (NASH) is associated with fibrosis and cirrhosis, and NASH-related cirrhosis is one of the main reasons for a liver transplantation in the United States today (5) . Although interactions between steatosis, fibrosis, and inflammation have been observed in many patients with NAFLD, with one disorder promoting the other, the underlying mechanism remains poorly understood.
The histological severity of NAFLD can be assessed with the steatosis, activity, and fibrosis (SAF) scoring system (6) . According to the SAF score, the grade of steatosis is classed as S0 to S3, the grade of activity is classed as A0 to A4, and the grade of fibrosis is classed as F0 to F4. In NAFLD, the SAF score incorporates both the grade of activity, which includes lobular inflammation and hepatocyte ballooning, and fibrosis (7) . In many ongoing clinical trials, the SAF score is used as a secondary endpoint (8) .
The role of chemokines in steatotic and fibrotic processes remains unclear because subgroups of chemokines have distinct functions (9) . CXC motif ligand 16 (CXCL16), which has soluble and transmembrane forms, is expressed in the liver, lung, kidney, and small intestine (10) (11) (12) . Previous studies indicated that CXCL16 was highly expressed in the liver of patients with metabolic and inflammatory liver diseases (13, 14) and that inhibition of CXCL16 diminished liver macrophage infiltration and steatohepatitis in chronic hepatic injury (15) .
The roles of hepatic stellate cells (HSCs) as primary collagen-producing cells in the liver and in fibrotic development in patients with NAFLD have been identified in recent years (16) (17) (18) . A hepatocyte-stellate cell coculture system is commonly used to study crosstalk between hepatocytes and HSCs. Previous research demonstrated that communication between hepatocytes and HSCs played an important role in maintaining liver-specific functions (19) . Studies also showed that various chemokines influenced HSC activation and subsequently altered fibrosis-related signaling pathways (20, 21) . However, whether and how CXCL16 regulates steatosis and fibrosis during NAFLD progression, mediated by HSC activation, remains unclear.
The Hedgehog (Hh) signaling cascade is an important pathway, which determines cell growth and tissue repair, and the major role of this pathway in metabolic liver disease has recently been identified (22) . The function of Hh ligands as regulators of liver metabolism by crosstalk with Wnt/beta-catenin signaling has also been recognized, as well as their roles as positive regulators of Wnt/betacatenin signaling (23, 24) . Hh signaling cascade ligands include Sonic Hedgehog (SHH), Indian Hedgehog, and Desert Hedgehog, which react with surface receptors Patched (PTCH) 1 and 2 (PTCH1 and PTCH2), leading to the activation of coreceptor Smoothened (SMO) (25) . Activated SMO enhances glioma-associated oncogene (GLI) transcription factors (GLI1, GLI2, and GLI3) by preventing GLI2 and GLI3 from converting transcriptional repressors (25, 26) . The Hh signaling cascade regulates liver metabolism in several ways, for example, by regulating the insulinlike growth factor axis in mature hepatocytes (27) . In hepatocytes, the transcription factors GLI1, GLI2, and GLI3 regulate several metabolic genes, including lipid-associated factors, and form a unique self-stabilizing network (28) . Hh signaling is also known to play an important role in NAFLD progression (29) .
In this study, we investigated the mechanism of action of CXCL16 in NAFLD progression in the steatotic and fibrotic process during NAFLD progression.
Materials and Methods

Study population
A total of 117 patients with biopsy-proven NAFLD from Beijing 302 Hospital were enrolled in this study. Sera and formalin-fixed and paraffin-embedded biopsy specimens were retrieved from the hospital's sample bank. All the liver specimens had been evaluated by three pathologists. Sera from 15 healthy controls who had visited the hospital for a routine health examination and 15 liver tissue samples from liver transplantation donors without background disease served as controls. Data on demographic characteristics and biochemistry parameters were collected from all enrolled subjects. Serum CXCL16 levels were measured with commercial ELISA kits (R&D, Minneapolis, MN). Approval for the study was obtained from the ethics committee of Beijing 302 Hospital.
Primary murine hepatocyte, HSC, and liver sinusoidal endothelial cell isolation
Normal male C57BL/6 mice (6 weeks old) were purchased from the Animal Center of 302 Hospital. C57BL/6 mice were fed a methionine-and choline-deficient diet for 4 weeks to induce NAFLD. The mice were anesthetized and exposed on an experimental board. A syringe pump was inserted into the portal vein. The liver was perfused with Hanks solution containing 0.1% collagenase (Wako, Osaka, Japan) suspended in PBS. The cells were centrifuged for 3 minutes at 500 rpm after passing through a 100-mm cell strainer. The pelleted cells were used as hepatocytes and cultured on a collagen-coated culture dish. The supernatant was used to isolate liver sinusoidal endothelial cells (LSECs). The cells were seeded on a collagencoated dish, and after 1 hour the dish was washed vigorously with DMEM (Invitrogen, Carlsbad, CA) to eliminate other cells. For HSC isolation, blood was flushed out, and an enzyme mixture (protease E, collagenase IV, and DNase (SigmaAldrich, St. Louis, MO) was perfused to digest the liver. The cell suspension was prepared via mincing, filtration, and centrifugation in a cell-Nycodenz mixture (Sigma-Aldrich) with density of 1.050 g/mL. The cell-Nycodenz mixture was covered with Hanks fluid (Gibco, Grand Island, NY) to create a discontinuous gradient. The white cell layer (HSCs) was extracted from the gradient interface.
Histology analyses and immunohistochemistry
Immunohistochemical staining of CXCL16 was performed on the 10% formalin-fixed, paraffin-embedded hepatic tissue samples from the enrolled patients, and liver sections were incubated with an affinity-purified mouse antibody against human CXCL16 (Abcam, Cambridge, MA) in a solution containing 3% BSA (Sigma-Aldrich) overnight at 4°C. Subsequently, the slices were incubated with a peroxidase-conjugated secondary antibody (Abcam). Successive sections were stained with CXCL16 antibody, smooth muscle a-actin (a-SMA) antibody for HSCs, and CD31 antibody for LSECs.
Lentiviral infection
A lentiviral vector encoding human CXCL16 was generated. Briefly, the coding regions of CXCL16 were cloned into a pRRL vector. The pRRL vector was subsequently used to generate a recombinant lentivirus in HEK-293T cells. Packaging vectors (pMDLg/pRRE and pRSV-REV) and a VSVG expression vector (pMD2G) were constructed according to standard protocols. 
Cell coculture model and oleic acid treatment
A normal human hepatocyte cell line, L02, and LX2 HSC line were purchased from the Shanghai Cell Collection (Shanghai, China). We used a culture insert (pore size 3.0 mm; Millipore, Billerica, MA). The isolated primary murine hepatocytes or L02 cells (2 3 10 5 ) were placed in the lower layer of Transwell dish, and the primary murine HSC or LX2 cells (2 3 10 5 ) were seeded on the upper layer of the Transwell (insert) dish (Corning Incorporated, Corning, NY). The cells were cultured in DMEM supplemented with 10% (v/v) fetal bovine serum (Invitrogen) and penicillin/streptomycin (100 U) (Life Technologies, Gaithersburg, MD). The system was incubated at 37°C with 5% CO 2 . The coculture system was then incubated in medium with oleic acid (OA) or without OA (Sigma-Aldrich) (0.75 mM).
Oil Red O (Sigma-Aldrich) (0.35% in isopropanol) was prepared as a stock solution and diluted in double-distilled H 2 O (3:2) before use. L02 cells were gently washed with PBS and then fixed with 4% paraformaldehyde for 1 hour at room temperature. The cells were stained with Oil Red O solution for 20 minutes. They were then washed with 60% isopropanol solution for 5 minutes to remove background staining. Lipid droplet accumulation was detected with a microscope at 4003, and Oil Red O stain was extracted by pure isopropanol. The optical density of the Oil Red O extracted was detected with a Spectramax 250 Plate Reader (Molecular Devices, Sunnyvale, CA) at 510 nm to quantify intracellular lipid accumulation.
Immunofluorescence assays
The primary murine hepatocytes were cultured on glass coverslips for 24 hours. After treatment, the hepatocytes were fixed with 4% paraformaldehyde, permeabilized in 0.1% Triton X-100 (Sigma-Aldrich), and blocked in PBS and 3% BSA for 30 minutes. They were then incubated with Cy3-labeled anti-CXCL16 antibody (Abcam) for 1 hour. Lipid content was detected with BODIPY 493/503 dye (Sigma-Aldrich) 1 hour after anti-CXCL16 staining. The nuclei of cells were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) for 10 minutes. The stained cells were observed with a laser scanning confocal microscope (Olympus, Tokyo, Japan).
Double immunofluorescence staining of 4-mm sections of the formalin-fixed paraffin-embedded tissue was performed. The slices were deparaffinized, hydrated, placed in prewarmed epitope retrieval solution, and boiled in a steam oven for 25 minutes. The slices were then removed and allowed to cool in the epitope retrieval solution at room temperature for 20 minutes. Subsequently, the slices were incubated with primary antibodies overnight at 4°C. After washing in PBS, the slices were incubated in the dark in DAPI for 15 minutes. The stained slices were observed with a laser-scanning confocal microscope (Olympus).
Intracellular triglyceride, superoxide dismutase, and reactive oxidative species assays
The quantification of triglyceride (TG), superoxide dismutase (SOD), and reactive oxidative species (ROS) was evaluated with specific kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), in accordance with the manufacturers' instructions. The protein concentrations of the cells were assayed by the bicinchoninic acid method.
RNA preparation and quantitative real-time PCR
The total RNAs from hepatocytes or HSCs were extracted with Trizol (Invitrogen), and the RNA samples were reversetranscribed to cDNA with A PrimeScript™ RT reagent kit (Takara, Tokyo, Japan). The levels of all mRNA transcripts were determined in triplicate by a quantitative real-time PCR assay with SYBR® Premix Ex Taq™ II (TliRNaseH Plus, Takara). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was amplified from each sample for normalization as a reference gene. The gene expression levels were compared with those of GAPDH, and expression changes were calculated with DDCt values.
Measurement of mitochondrial oxygen consumption
L02 cells or primary murine hepatocytes (2 3 10 4 per well) were seeded in the XF plate of a Seahorse XF96 analyzer (Seahorse Bioscience, Billerica, MA) and incubated with medium from the coculture system for 48 hours. For measurement of mitochondrial oxygen consumption, the growth medium was replaced with 175 mL of XF assay medium (Seahorse Bioscience), supplemented with 25 mM glucose and 2 mM sodium pyruvate (pH 7.4). Hepatocytes were incubated in a non-CO 2 incubator for 60 minutes at 37°C. For bioenergetics assessments, 1.0 mM/mL of oligomycin was used to inhibit ATP synthase activity, 2.4 mM trifluorocarbonylcyanidephenylhydrazone was used to uncouple mitochondrial oxidative phosphorylation, and 1 mM rotenone and antimycin A were used to inhibit electron transport in complexes I and III. These mitochondrial inhibitors were used to determine mitochondrial function parameters.
Western blotting
After extraction and quantitation of total proteins from hepatocytes, HSCs, or LSECs, 50 mg of total proteins from each group was separated by 10% SDS polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride (PVDF) (Millipore) membranes. The PVDF membranes were incubated overnight at 4°C with the following primary antibodies: hepatic-specific antigen, CD31, a-SMA, collagen type I a 1 (COL1A1), TGF-b receptors (TGF-b RI/II), connective tissue growth factor (CTGF), platelet-derived growth factor (PDGF)-b receptor, B-cell lymphoma-2-associated X protein (BAX), cyclin D1, B-cell lymphoma-2 (Bcl-2), cyclin D1, Hh ligands (SHH, SMO, PTCH1, GLI1, and GLI3), peroxisome proliferator-activated receptor (PPAR)-a, PPAR-g, sterol regulatory element binding protein-1 (SREBP-1) antibodies (Cell Signaling Technology, Danvers, MA), b-actin, GAPDH, and b-tubulin (Sigma-Aldrich). The PVDF membranes were washed and subsequently incubated with secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) at 37°C for 2 hours. Bound proteins were visualized via electrochemiluminescence (Pierce, Rockford, IL).
Statistical analysis
The data were analyzed in SPSS version 23.0 (IBM SPSS Statistics). Differences between the control group and NAFLD group were analyzed via the Mann-Whitney test for nonnormally distributed variables. For comparison of nonnormally distributed continuous variables among the control, S0-1, S2, and S3 groups, the Kruskal-Walls test was conducted, with a one-way ANOVA performed as a post hoc test. P , 0.05 was considered statistically significant.
Results
Characteristics of the study population
In total, 117 patients with NAFLD (61 men and 56 women) were diagnosed by a liver biopsy. These patients were classified into three groups (S0-1, S2, and S3) according to their SAF scores (7) . Compared with the healthy control group, patients with NAFLD had a higher body mass index and higher alanine transaminase and aspartate transaminase levels (P , 0.05). In terms of lipid profiles, the TG levels of patients with NAFLD were higher than those of the healthy controls (P , 0.05). There was also a significant difference in the levels of hepatic injury-related factors, such as alanine transaminase, aspartate transaminase, and TG, in patients with NAFLD in groups S0-1, S2, and S3 compared with those in healthy subjects.
Serum CXCL16 levels were elevated in subjects with severe steatosis, active inflammation, and late-stage fibrosis Circulating levels of CXCL16 in patients with different grades of steatosis were explored. As expected, serum CXCL16 levels were significantly elevated in patients with NAFLD as compared with those in healthy controls (P , 0.05). The CXCL16 levels in the S2 and S3 groups were higher than that in the healthy control group, and the level in the S3 group was higher than that in the S0-1 group (P , 0.05). Surprisingly, a stratified analysis performed to further analyze the data revealed that the increase in serum CXCL16 levels in S2 and S3 groups was explained primarily by the presence of patients with scores of A $2 or F $2 [ Fig. 1(a) ]. There was no significant difference in serum CXCL16 levels among https://academic.oup.com/jcemthe S0-1, S2, and S3 groups with scores of A #1 and F #1. There were no significant differences in serum CXCL16 levels associated with sex. Analysis of CXCL16 expression in liver tissue of patients with NAFLD detected strong expression of CXCL16 surrounding lipid droplets of liver tissues, especially in samples obtained from patients with severe disease. The CXCL16 expression was also detected in sections without steatosis (parasteatosis) and in healthy controls but quite moderate [ Fig. 1(b) ]. Double immunofluorescence staining of CXCL16 in specimens obtained from patients with NAFLD with markers of different cell types revealed moderate hepatocyte expression of CXCL16 [ Fig. 1(c) ]. A few HSCs and LSECs strongly expressed CXCL16 according to immunofluorescence staining, but successive section immunohistochemistry showed no such trend [ Fig. 1(d) ]. As shown by quantitative real-time PCR and Western blot assays of cxcl16 expression in the various cell types of mice with NAFLD. cxcl16 expression was increased in hepatocytes and HSCs of mice with NAFLD, but the cxcl16 expression in LSECs decreased in the NAFLD group [ Fig. 1(e) ].
CXCL16 expression increased lipid accumulation in hepatocytes in a cell coculture system and increased mitochondrial stress levels OA induced severe steatosis in CXCL16+ hepatocytes when they were cocultured with HSCs. However, after OA treatment of 12 hours, there was no difference in steatosis in OA-treated CXCL16+ hepatocytes as compared with that in nontreated cells (CXCL162). Interestingly, more lipids accumulated in the cytoplasm of the CXCL16+/coculture group than in the CXCL162/coculture group. No significant difference was found between CXCL16+ hepatocytes alone and CXCL162 hepatocytes in the coculture system when both treated with OA [ Fig. 2(a) ]. As shown by lipid staining with BODIPY in primary murine hepatocytes stimulated by OA, lipid droplets were larger in the CXCL16+ hepatocyte-stellate cell coculture group [ Fig. 2(b) ]. CXCL16 overexpression increased intracellular TG accumulation and enhanced SOD and ROS activity in hepatocytes in the coculture system. We then determined the influence of CXCL16 on TG accumulation, as well as on ROS and SOD activity. After the cells were infected with CXCL16 lentivirus, each group was treated with OA (0.75 mmol/L) for 12 hours or received no OA treatment. As shown in Fig. 2(a) and 2(b) , CXCL16 overexpression significantly increased the hepatic TG level and enhanced ROS and SOD activity in hepatocytes treated with OA (0.75 mmol/L) in the coculture system, whereas the effects of CXCL16 expression in hepatocytes were moderate in the other groups. To investigate whether CXCL16 and OA treatment activated steatosis-related gene expression, the coculture system was treated with or without CXCL16 and incubated with or without OA. The results revealed that PPAR-a, PPAR-g, and SREBP-1 were significantly higher in the OA-treated groups, with the difference between the CXCL16+/OA treatment group and CXCL162/ OA treatment group particularly noticeable [ Fig. 2(c) ].
CXCL16 influenced mitochondrion function and reduced oxygen consumption rates
After demonstrating that CXCL16 induced severe steatosis in hepatocytes in the coculture system, we directly measured mitochondrial oxygen consumption rates and stress levels over time after CXCL16 exposure. Basal respiration was measured to assess the effects of CXCL16 on the instantaneous respiration rate of hepatocytes. We simultaneously measured key parameters of mitochondrial bioenergetics (basal respiration, ATP-linked respiration, and respiration capacity) after CXCL16 overexpression. Hepatocytes were treated with the supernatant from each group, and mitochondrial-related parameters were then detected (Fig. 3) . As depicted in the Seahorse bioenergetics map, hepatocytes treated with the supernatant from the CXCL16+/coculture group showed a dramatic change in all three stages of mitochondrial respiration, in contrast with that of the other groups. Other treated groups also showed significant changes in contrast to the control group. The basal respiration rate, ATP-linked oxygen consumption rate, reserve respiration capacity, and maximal respiration rate were significantly different in the CXCL16+ and CXCL162 coculture groups (P , 0.05) [ Fig. 3(c) ].
CXCL16 activated HSCs in the coculture system and induced HSC proliferation CXCL16 overexpression in the coculture system increased HSC proliferation as compared with that in a control system (CXCL162) and upregulated mRNA expression of HSC activation-related genes, including a-SMA, COL1A1, TGFbRI/II, CTGF, and PDGF-b receptor. The results revealed decreased expression of proapoptotic BAX and increased expression of CYLCIN D1 and antiapoptotic BCL-2 in HSCs in the CXCL16 overexpression group, consistent with the observed increase in cell proliferation (Fig. 4) . Double staining for CXCR6 with different cell markers was performed in the specimens of patients with NAFLD. Interestingly, a few a-SMA-positive HSCs expressed CXCR6. In HSCs in the OA-stimulated coculture system, CXCR6 was undetectable in primary murine HSCs. These findings collectively suggested that overexpression of CXCL16 in the coculture system enhanced cell proliferation of HSCs and increased the expression of genes related to stellate cell activation. CXCR6+ activation HSCs may act as a receptor of CXCL16. CXCL16-regulated hepatocytes may play a role in HSC activation in vivo, and CXCR6+ activation HSCs could be an important receptor of CXCL16 expressed by hepatocytes [ Fig. 4(d) ]. 
Coculture of hepatocytes and HSCs activated the Hh pathway in hepatocytes
To check whether Hh signaling augmented HSC activation and hepatocyte steatosis in a paracrine manner, we examined Hh signaling mRNA (SHH, SMO, PTCH1, GLI1, GLI2, and GLI3) expression levels in the CXCL16+ coculture group. The results revealed that SHH, SMO, PTCH1, GLI1, GLI2, and GLI3 mRNA were downregulated, whereas there was no difference in GLI2 mRNA expression between the CXCL16+ and CXCL162 groups. Protein expression measured by Western blot paralleled mRNA expression. Representative examples of Hh signaling protein expression in hepatocytes and the HSCs-activated Hh signaling pathway in CXCL16+ hepatocytes are shown in Fig. 5(a) and 5(b) .
To identify other mediators associated with the mutual stimulatory effect on hepatocytes and HSCs, we used ELISA kits to detect the supernatant. Epithelial growth factor, TGF-b1, IGF-1, and PDGF-BB were elevated in the CXCL16 +/coculture system. The findings indicated that communication between hepatocytes and HSCs may be transmitted by exosomes secreted by hepatocytes and HSCs [ Fig. 5(c) ].
SHH overexpression blocked the stimulatory effect of CXCL16 on hepatocytes
Hepatocytes were infected with a recombinant SHH lentivirus to activate Hh signaling. The infected cells were then cocultured with HSCs. CXCL16 did not induce severe steatosis of hepatocytes pretreated with the SHH lentivirus in the coculture system [ Fig. 6(a) ]. SHH overexpression decreased steatosis induced by CXCL16 in hepatocytes when cocultured with HSCs but had no such influence in the system lacking HSCs. These findings revealed increased hepatocyte susceptibility to overexpression of Hh ligands when cocultured with HSCs [ Fig. 6 (b) and 6(c)].
Discussion
Increasing evidence suggests that chemokines may be associated with multiple disorders, including fibrosis, inflammation, and nonalcoholic fatty liver (9) . The current study indicated that serum CXCL16 levels were markedly elevated in patients with NAFLD and that this increase was attributed to the combined effects of steatosis, inflammation, and fibrosis. Patients with severe steatosis expressed higher CXCL16 levels in liver tissue and elevated serum CXCL16 levels. In groups with A or F scores $2, the trend was the same as the total analysis. Controversially, the group with A and F scores ,2 points revealed no significant difference. Taken together, these clinical data suggest that CXCL16 may be a biomarker of the onset and deterioration of liver steatosis and fibrosis in NAFLD. Furthermore, elevated serum CXCL16 levels may be related to abnormal lipid metabolism in subjects with NAFLD. CXCL16 is produced by LSECs, hepatocytes, cholangiocytes, dendritic cells, and macrophages (14, 20, 30, 31) . In our study, most hepatocytes, some LSECs, and some HSCs expressed CXCL16. Although CXCL16 expression in hepatocytes was not particularly strong, the population of hepatocytes in the liver is huge. Therefore, CXCL16 produced by hepatocytes should be considered an important source of the whole amount of CXCL16 in NAFLD or other types of liver injury.
Oxidative stress mediated by ROS plays a major role in initiating steatosis and cell damage and is associated with fatty liver disease (32) . The latter fact points to the possibility of using antioxidants to inhibit CXCL16-induced liver steatosis. Oxidative stress in hepatocytes is associated with an increase in serum lipids, in addition to ROS and SOD activity (32) . Lipid-generated oxidative stress led to mitochondrial dysfunction, followed by inflammation and progression of hepatic fibrosis. Impaired mitochondrial dysfunction also reduces the mitochondrial oxygen consumption rate and increased the TG level and expression of indices of oxidative stress (32) . CXCL16 triggers mitochondrial dysfunction in hepatocytes. PPAR-g and SREBP-1 play a crucial role in lipid metabolism, and both contribute to the regulation of liver lipogenesis (33, 34) . In the current study, PPAR-g and SREBP-1 expression levels in the CXCL16+/OA treatment group were increased by CXCL16 stimulation. CXCL16 expression also stimulated steatosis in the coculture system. PPAR-a expression was slightly increased. Previous studies reported that PPAR-a played a role in natural killer T (NKT) cell survival (35) . NKT cells are the main cells expressing CXCR6, which is the unique receptor of CXCL16. Therefore, PPAR-a expression in the CXCL16 overexpressing system was closely related to NKT cell function. The results of the current study and those in the literature point to various functions of PPAR-a in steatosis, inflammation, and the fibrotic process in NAFLD progression (33) .
The complex interplay between steatotic hepatocytes and HSCs is regulated by extracellular factors, including chemokines and circulating free fatty acids during steatotic and fibrotic processes. CXCL16 has a unique receptor named CXCR6. The chemotactic function of CXCL16 is closely related with CXCR6+ cells. Commonly, NKT cells are the main cell type that expresses CXCR6 (36) . Interestingly, in the current study, some HSCs were positive stained with CXCR6 staining. Activated HSCs show similar characteristics as myofibroblasts, such as a-SMA expression. Previous research showed that mesenchymal stem cells, which can differentiate into myofibroblasts, expressed CXCR6 in their homing process (37) (38) (39) (40) HSCs' myofibroblast characters may be the reason for their CXCR6 expression. Meanwhile, HSCs also expressed CXCL16 in our immunofluorescence staining. Autocrine of CXCL16 in HSCs could be another way by which CXCL16 influences NAFLD progression related to HSCs.
In the current study, CXCL16 activated HSCs in the coculture system. Activated HSCs are crucial for the progression of NAFLD, and they are a source of collagen (17) . Activated HSCs are the main collagen-producing cells in the liver. A recent study also provided evidence that HSCs play a crucial role in regulating the inflammatory process, and the immune system response, in liver injury. The immune regulatory function of HSCs depends on the type of liver injury and state of HSC activation (20, 21) . The findings of the current study point to a link between hepatocytes and HSCs, suggesting that CXCL16 regulates lipid metabolism, mitochondrial function, and inflammation in NAFLD progression. Chemokines and exosomes interact with HSCs via direct and indirect communication. Progress in understanding the role of HSCs as active regulators of liver metabolism may lead to therapeutic strategies for NAFLD.
In the current study, crosstalk between CXCL16+ hepatocytes and HSCs influenced Hh signaling. Hh signaling augmented HSC activation and hepatocyte steatosis in a paracrine manner. Hh signaling usually occurs via canonical and noncanonical pathways. In canonical Hh signaling, SHH, Indian Hedgehog, and Desert Hedgehog interact with surface receptors PTCH1 and PTCH2, resulting in noninhibition of SMO. Active SMO then triggers the activation of transcription factors (27) . The alteration in lipid metabolism was a consequence of hepatic Hh signaling regulation in adult liver and in vitro. Impaired Hh signaling leads to liver steatosis and fibrosis (28).
Our study establishes four functions of CXCL16:
1. CXCL16 intrahepatic expression and serum levels were both significantly elevated in subjects with NAFLD and closely associated with liver injury. Thus, CXCL16 may be involved in the pathogenesis of NAFLD. The latter warrants further investigation. 2. CXCL16 potentiated HSC-related oxidative stress, potentially causing hepatocyte steatosis. 3. CXCL16 activated HSCs, the main source of collagen in the liver, via the crosstalk between hepatocytes and stellate cells. 4. CXCL16 functioned as a potential inhibitor of the Hh signaling pathway in hepatocytes in NAFLD progression and led to severe steatosis in hepatocytes. Thus, CXCL16 could be used as a biomarker to distinguish different periods of steatosis, inflammation, and fibrosis in NAFLD and to evaluate activity and the risk of progression. In addition, CXCL16 may serve as a treatment target in NAFLD.
At present, there are no clinically available drugs that specifically inhibit CXCL16, although several CXCL16 inhibitors are available for research use. A phase IIa trial of a CXCL16 inhibitor named AZD3241 has been completed, and several preclinical candidates are under development. Fortunately, most people with hereditary CXCL16 deficiency are asymptomatic, and this phenomenon can be an additional benefit of research targeting CXCL16.
There are several limitations of this study. The first is that this study cohort was small. Furthermore, the causal relationship between CXCL16 and the pathogenesis of patients with NAFLD could not be addressed. Larger sample sizes are needed to determine whether CXCL16 can be used as a biomarker in diagnosing and evaluating the onset and development of NAFLD.
Collectively, our study reveals an important role for CXCL16 in regulating hepatic lipid metabolism and fibrosis via hepatocyte-stellate cell crosstalk. These findings suggest a paradigm for the development of liver steatosis, in which the impairment of Hh signaling promotes steatosis, independent of nutritional changes. Malfunction in this pathway may pave the way for the development of NAFLD and lead to further aggravation.
